In patients with melanoma and non-small cell lung cancer, TOX expression is significantly higher in CD8+T lymphocytes, a phenomenon that is positively correlated with the expression of PD-1, TIM3, CTLA4, and other IRs. The gene discussed is CD8A; the disease is non-small cell lung carcinoma.